Back

ANDAMAN - Aspirin twice a day and Acute Coronary Syndrome

30 August 2025 (17:45 - 18:00)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Trials: cardiovascular risk and prevention Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Jean-Guillaume Dillinger

Hospital Lariboisiere, Paris (France)

3 More presentations in this session

Presentation thumbnail
Biomarker-guided risk management following acute coronary syndromes
Professor R. Doughty (Auckland, NZ)
Slides Video
Presentation thumbnail
CAC CV-PREVITAL Coronary Artery Calcium Scoring in primary prevention
Doctor G. Ferrante (Milan, IT)
Slides Video
Presentation thumbnail
CONFIDENCE: ambulatory blood pressure monitor substudy
Doctor M. Vaduganathan (Boston, US)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Trials: cardiovascular risk and prevention
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 17:45 CET
You may be interested in
thumbnail
Congress Presentation
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
31 August 2025
thumbnail
Congress Presentation
Aspirin reloading before percutaneous coronary intervention on chronic aspirin therapy: reduced early ischemia without bleeding trade-off
29 August 2025
thumbnail
Congress Presentation
TADCLOT- Twice A Day CLOpidogrel vs. Ticagrelor post STEMI
30 August 2025
thumbnail
Congress Presentation
Discussant review - AQUATIC
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources